TW200639170A - Pharmaceutical compounds - Google Patents
Pharmaceutical compoundsInfo
- Publication number
- TW200639170A TW200639170A TW095101704A TW95101704A TW200639170A TW 200639170 A TW200639170 A TW 200639170A TW 095101704 A TW095101704 A TW 095101704A TW 95101704 A TW95101704 A TW 95101704A TW 200639170 A TW200639170 A TW 200639170A
- Authority
- TW
- Taiwan
- Prior art keywords
- kinases
- methyl
- group
- compounds
- pharmaceutical compounds
- Prior art date
Links
Abstract
The invention provides compounds of the formula (I), or a salt, tautomer, solvate or N-oxides thereof; wherein: R1 is selected from (a) 2,6-dichlorophenyl; (b) 2,6-difluorophenyl; (c) a 2,3,6-trisubstituted phenyl group wherein the substituents are fluorine, chlorine, methyl or methoxy; and (d) a group R0 wherein R0 is a 3-12 membered carbocyclic or heterocyclic group; or optionally substituted C1-8 hydrocarbyl; R2a and R2b are each hydrogen or methyl; and R3 is as defined in the claims. The compounds have activity as inhibitors of Cyclin Dependent Kinases (CDK) and Glycogen Synthase Kinases (GSK) kinases and are useful in the treatment or prophylaxis of disease states or conditions mediated by the kinases.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64621705P | 2005-01-21 | 2005-01-21 | |
GB0501480A GB0501480D0 (en) | 2005-01-22 | 2005-01-22 | Pharmaceutical compounds |
GB0501748A GB0501748D0 (en) | 2005-01-27 | 2005-01-27 | Pharmaceutical compounds |
US65133905P | 2005-02-09 | 2005-02-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200639170A true TW200639170A (en) | 2006-11-16 |
Family
ID=45699652
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095101695A TW200637858A (en) | 2005-01-21 | 2006-01-17 | Pharmaceutical compounds |
TW095101704A TW200639170A (en) | 2005-01-21 | 2006-01-17 | Pharmaceutical compounds |
TW095101705A TW200640922A (en) | 2005-01-21 | 2006-01-17 | Pharmaceutical compounds |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095101695A TW200637858A (en) | 2005-01-21 | 2006-01-17 | Pharmaceutical compounds |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095101705A TW200640922A (en) | 2005-01-21 | 2006-01-17 | Pharmaceutical compounds |
Country Status (3)
Country | Link |
---|---|
GT (3) | GT200600015A (en) |
MY (1) | MY139848A (en) |
TW (3) | TW200637858A (en) |
-
2006
- 2006-01-11 GT GT200600015A patent/GT200600015A/en unknown
- 2006-01-11 GT GT200600014A patent/GT200600014A/en unknown
- 2006-01-11 GT GT200600016A patent/GT200600016A/en unknown
- 2006-01-17 TW TW095101695A patent/TW200637858A/en unknown
- 2006-01-17 TW TW095101704A patent/TW200639170A/en unknown
- 2006-01-17 TW TW095101705A patent/TW200640922A/en unknown
- 2006-01-18 MY MYPI20060218 patent/MY139848A/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW200640922A (en) | 2006-12-01 |
GT200600014A (en) | 2006-08-09 |
GT200600016A (en) | 2006-08-09 |
GT200600015A (en) | 2006-08-09 |
TW200637858A (en) | 2006-11-01 |
MY139848A (en) | 2009-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN07279A1 (en) | Pyrazole derivatives for the inhibition of cdk's and gsk's | |
NO20062726L (en) | New pyridazine-3 (2H) -one derivatives | |
PH12020551692A1 (en) | 2-amino-pyrimidine derivatives as cyclin dependent kinase inhibitors | |
PE20090887A1 (en) | DERIVATIVES OF 1H-PYRAZOLE- [3,4-d] -PYRIMIDINE, 9H-PURINE AND 7H-PYRROL- [2,3-d] -PYRIMIDINE AS KINASE INHIBITORS P70 S6 | |
NO20070532L (en) | Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors | |
MXPA05013349A (en) | 2-aminopyrimidine derivatives as raf kinase inhibitors. | |
NO20053144L (en) | Chk, Pdk, and Akt inhibitor pyrimidines, their preparation and use as famasoytic agents. | |
NO20073926L (en) | Pyrazole compounds that modulate activity of CDK, GSK and aurorakinases | |
NO20080675L (en) | P38-Map kinase inhibitors and methods for their use | |
NO20082934L (en) | Antiviral nucleotides | |
NO20090580L (en) | Cyclopenta [D] pyrimidines as AKT protein kinase inhibitors | |
NZ533310A (en) | Benzimidazoles useful as protein kinase inhibitors | |
WO2007044724A3 (en) | Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3 | |
NO20063028L (en) | 6-substituted 2-quinolinones and 2-quinoxalinones as poly (adp-ribose) polymerase inhibitors | |
NO20062892L (en) | 7-Phenylalkyl-substituted 2-quinolinones and 2-quinoxalinones as poly (adp-ribose) polymerase inhibitors | |
NO20070557L (en) | Phthalazine derivatives as PARP inhibitors | |
NO20045677L (en) | Inhibitors of JAK and CDK2 protein kinases | |
TNSN06411A1 (en) | Pyrimidine urea derivatives as kinase inhibitors | |
WO2005002576A8 (en) | Imidazole derivatives and their use as protein kinases inhibitors | |
MY145106A (en) | 1-(b-d-glycopyranosyl)-3-(cyclopropylphenylmethyl)-4-halogeno indole derivatives and use thereof as sglt inhibitors | |
MXPA05008878A (en) | N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors. | |
NO20051339L (en) | Use of lkB kinase inhibitors in the treatment of pain. | |
WO2006047479A3 (en) | C-fms kinase inhibitors | |
NO20053133L (en) | Chemical connections. | |
TW200612964A (en) | Methods for preparing p2x7 inhibitors |